Adroit Biomed Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 05-07-2024
- Paid Up Capital ₹ 4.25 M
as on 05-07-2024
- Company Age 15 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.75 Cr
as on 05-07-2024
- Revenue 27.82%
(FY 2023)
- Profit -6.19%
(FY 2023)
- Ebitda -12.53%
(FY 2023)
- Net Worth 29.56%
(FY 2023)
- Total Assets 7.63%
(FY 2023)
About Adroit Biomed
The Corporate was formerly known as Adroit Biomed Private Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 4.25 M.
The company currently has active open charges totaling ₹2.75 Cr.
Darshak Shah, Jagjeet Ahluwalia, Sushant Raorane, and Six other members serve as directors at the Company.
- CIN/LLPIN
U22100MH2009PLC197761
- Company No.
197761
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Adroit Biomed Limited offer?
Adroit Biomed Limited offers a wide range of products and services, including Face Cream, Fairness Cream, Skin Creams, Beauty Cream, Beauty Services, Gold Facial, Hair Care Products.
Who are the key members and board of directors at Adroit Biomed?
Board Members(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Darshak Shah  | Director | 03-May-2017 | Current |
| Ajit Marathe | Director | 19-Oct-2010 | Current |
Jagjeet Ahluwalia  | Director | 24-Jul-2018 | Current |
| Sushant Raorane | Director | 19-Oct-2010 | Current |
| Manish Bhachoo | Director | 03-May-2017 | Current |
Anil Sharma  | Director | 13-Jul-2017 | Current |
Financial Performance and Corporate Structure Insights of Adroit Biomed.
Adroit Biomed Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.82% increase. The company also saw a slight decrease in profitability, with a 6.19% decrease in profit. The company's net worth Soared by an impressive increase of 29.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adroit Biomed?
In 2023, Adroit Biomed had a promoter holding of 81.82% and a public holding of 18.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nutragenix Healthcare Private LimitedActive 7 years 8 monthsDarshak Shah and Sameer Paigankar are mutual person
My Healthskape Medicals Private LimitedActive 21 years 8 monthsManish Bhachoo and Sameer Paigankar are mutual person
Lavue Pharmaceuticals Private LimitedActive 15 years 2 monthsDarshak Shah and Sameer Paigankar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Apr 2013 | ₹2.75 Cr | Open |
How Many Employees Work at Adroit Biomed?
Adroit Biomed has a workforce of 135 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adroit Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adroit Biomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
